Ipsen Q3 Sales Rise 28%, Company Upgrades FY26 Outlook
Ipsen said third-quarter total sales rose 28%, helped by its rare disease division, and upgraded its annual outlook.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.